Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-03-07 @ 5:13 PM
Study NCT ID:
NCT02946333
Status:
COMPLETED
Last Update Posted:
2022-11-22
First Post:
2016-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-30
First Submit QC Date:
None
Study First Post Date:
2016-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-18
Last Update Post Date:
2022-11-22
Last Update Post Date Type:
ACTUAL